Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,327.00
+7.00 (0.53%)
May 13, 2025, 1:00 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 82.07 billion as of May 13, 2025. Its market cap has decreased by -35.83% in one year.
Market Cap
82.07B
Enterprise Value
78.99B
Revenue
21.64B
Ranking
n/a
PE Ratio
10.81
Stock Price
1,327.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 82.07B, an increase of 2,127.71%. That is a compound annual growth rate of 13.46%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,972.27B |
| Coloplast | 144.15B |
| Demant | 53.21B |
| ALK-Abelló | 36.25B |
| Zealand Pharma | 30.31B |
| H. Lundbeck | 29.15B |
| Ambu A/S | 27.44B |
| GN Store Nord | 13.28B |